Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta. Reviews on Cancer|November 11, 2023
Finding the junction between claudins and endometrial carcinomaDavide Capoferri, Eliana Bignotti, Antonella Ravaggi, et al.
Biomedicines|November 27, 2025
Clinical Significance of Soluble L1CAM Serum Levels in Patients with High-Risk Endometrial CancerAntonella Ravaggi, Cosetta Bergamaschi, Laura Zanotti, et al.
American Journal of Obstetrics and Gynecology|May 12, 2009
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomasChiara Romani, Fabrizio Comper, Elisabetta Bandiera, et al.
ISRN Obstetrics and Gynecology|July 14, 2012
Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancerElisabetta Bandiera, Roberta Franceschini, Claudia Specchia, et al.
Cancer Treatment Reviews|October 20, 2023
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapyDavide Smussi, Davide Mattavelli, Alberto Paderno, et al.
Gynecologic Oncology|April 26, 2003
Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervixAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genesEliana Bignotti, Renata A Tassi, Stefano Calza, et al.
Journal of Cellular and Molecular Medicine|July 16, 2016
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissuesEliana Bignotti, Stefano Calza, Renata A Tassi, et al.
Gynecologic Oncology|March 9, 2007
Overexpression of mammaglobin B in epithelial ovarian carcinomasRenata A Tassi, Eliana Bignotti, Elisa Rossi, et al.
Frontiers in Oncology|November 2, 2020
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma PatientsEliana Bignotti, Laura Zanotti, Paola Todeschini, et al.
Pageof 8